FT-002 Clinical Trials
2 recruitingGenetic
Phase 11Phase 21Early Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa
X-Linked Retinitis Pigmentosa (XLRP)
Frontera Therapeutics32 enrolled1 locationNCT06492850
Recruiting
Early Phase 1
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
X-Linked Retinitis Pigmentosa
Frontera Therapeutics18 enrolled2 locationsNCT05874310